Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Researchers at Apotex present new thymodepressin prodrugs

Sep. 12, 2013

Novel TYK2 inhibitors divulged by Takeda Pharmaceuticals

Sep. 10, 2013

Clinical comparison and evaluation of treatment dressings in skin graft donors

Sep. 5, 2013

Lipidor's phase I/II trial of Akvano/calcipotriol spray meets primary endpoint

Aug. 27, 2013

FDA approves first topical therapy for erythema in patients with rosacea

Aug. 27, 2013

HypoThermosol used in two Intercytex trials of cell-based wound care

Aug. 23, 2013

Velocity Pharmaceutical Development announces collaboration and VPD-737 IND

Aug. 21, 2013

Grafix shows efficacy in stem cell study for diabetic foot ulcers

Aug. 16, 2013

Biocon launches ALZUMAb in India

Aug. 13, 2013

Telormedix receives funding for new psoriasis treatment

Aug. 9, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...